Similarly, transmembrane protein Myelin and lymphocyte 2 (MAL2) that is frequently overexpressed in breast cancer [118] associates with pMHC-I complexes to promote endocytosis and degradation [119]; MAL2 knockdown improved tumor recognition and T-cell activation [119]. Here, MAL2 is linked to breast cancer.